Search research articles
Contact Us
Filters
Showing results (21-30 of 101) with videos related to
Page
of 11
Sort By:
Regenerative Medicine
|
May 22, 2007
Translational regenerative medicine research: essential to discovery and outcome
Chris Mason, Peter Dunnill
Regenerative Medicine
|
March 26, 2009
Revolutionary therapies for diabetes--catalysts for change. Foreword
Chris Mason, Elisa Manzotti
Regenerative Medicine
|
March 26, 2009
Quantities of cells used for regenerative medicine and some implications for clinicians and bioprocessors
Chris Mason, Peter Dunnill
Regenerative Medicine
|
December 16, 2011
Human embryonic stem cell therapy in the post-Geron era
David Brindley, Chris Mason
Regenerative Medicine
|
October 3, 2007
Lessons for the nascent regenerative medicine industry from the biotech sector
Chris Mason, Peter Dunnill
Tissue Engineering
|
May 24, 2007
Regenerative medicine bioprocessing: building a conceptual framework based on early studies
Chris Mason, Mike Hoare
Regenerative Medicine
|
May 9, 2008
The strong financial case for regenerative medicine and the regen industry
Chris Mason, Peter Dunnill
Regenerative Medicine
|
December 19, 2009
Stem cell nations working together for a stem cell world
Chris Mason, Elisa Manzotti
Regenerative Medicine
|
July 20, 2007
Mapping the human embryome: 1 to 10e13 and all the cells in between
Michael D West, Chris Mason
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
|
September 30, 2015
Cells: from Robert Hooke to cell therapy--a 350 year journey
Johan Hyllner, Chris Mason, Ian Wilmut
Page
of 11
Search research articles
Search
Showing results (21-30 of 101) with videos related to
Sort By:
Page
of 11
Regenerative Medicine
|
May 22, 2007
Translational regenerative medicine research: essential to discovery and outcome
Chris Mason, Peter Dunnill
Regenerative Medicine
|
March 26, 2009
Revolutionary therapies for diabetes--catalysts for change. Foreword
Chris Mason, Elisa Manzotti
Regenerative Medicine
|
March 26, 2009
Quantities of cells used for regenerative medicine and some implications for clinicians and bioprocessors
Chris Mason, Peter Dunnill
Regenerative Medicine
|
December 16, 2011
Human embryonic stem cell therapy in the post-Geron era
David Brindley, Chris Mason
Regenerative Medicine
|
October 3, 2007
Lessons for the nascent regenerative medicine industry from the biotech sector
Chris Mason, Peter Dunnill
Tissue Engineering
|
May 24, 2007
Regenerative medicine bioprocessing: building a conceptual framework based on early studies
Chris Mason, Mike Hoare
Regenerative Medicine
|
May 9, 2008
The strong financial case for regenerative medicine and the regen industry
Chris Mason, Peter Dunnill
Regenerative Medicine
|
December 19, 2009
Stem cell nations working together for a stem cell world
Chris Mason, Elisa Manzotti
Regenerative Medicine
|
July 20, 2007
Mapping the human embryome: 1 to 10e13 and all the cells in between
Michael D West, Chris Mason
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
|
September 30, 2015
Cells: from Robert Hooke to cell therapy--a 350 year journey
Johan Hyllner, Chris Mason, Ian Wilmut
Page
of 11